BR112022017653A2 - Uso de compostos no tratamento de infecções fúngicas - Google Patents

Uso de compostos no tratamento de infecções fúngicas

Info

Publication number
BR112022017653A2
BR112022017653A2 BR112022017653A BR112022017653A BR112022017653A2 BR 112022017653 A2 BR112022017653 A2 BR 112022017653A2 BR 112022017653 A BR112022017653 A BR 112022017653A BR 112022017653 A BR112022017653 A BR 112022017653A BR 112022017653 A2 BR112022017653 A2 BR 112022017653A2
Authority
BR
Brazil
Prior art keywords
treatment
fungal infections
compounds
fungal
infections
Prior art date
Application number
BR112022017653A
Other languages
English (en)
Portuguese (pt)
Inventor
joy Shaw Karen
Hodges Michael
Original Assignee
Amplyx Pharmaceuticals Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Amplyx Pharmaceuticals Inc filed Critical Amplyx Pharmaceuticals Inc
Publication of BR112022017653A2 publication Critical patent/BR112022017653A2/pt

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
    • A61K31/4427—Non condensed pyridines; Hydrogenated derivatives thereof containing further heterocyclic ring systems
    • A61K31/444—Non condensed pyridines; Hydrogenated derivatives thereof containing further heterocyclic ring systems containing a six-membered ring with nitrogen as a ring heteroatom, e.g. amrinone
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/66—Phosphorus compounds
    • A61K31/675—Phosphorus compounds having nitrogen as a ring hetero atom, e.g. pyridoxal phosphate
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K45/00—Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
    • A61K45/06—Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/10—Antimycotics

Landscapes

  • Health & Medical Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Chemical & Material Sciences (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Epidemiology (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Oncology (AREA)
  • Communicable Diseases (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Dermatology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicinal Preparation (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
BR112022017653A 2020-03-04 2021-03-02 Uso de compostos no tratamento de infecções fúngicas BR112022017653A2 (pt)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US202062985274P 2020-03-04 2020-03-04
PCT/US2021/020471 WO2021178406A1 (en) 2020-03-04 2021-03-02 Use of compounds in the treatment of fungal infections

Publications (1)

Publication Number Publication Date
BR112022017653A2 true BR112022017653A2 (pt) 2022-10-18

Family

ID=77612811

Family Applications (1)

Application Number Title Priority Date Filing Date
BR112022017653A BR112022017653A2 (pt) 2020-03-04 2021-03-02 Uso de compostos no tratamento de infecções fúngicas

Country Status (11)

Country Link
US (2) US12521406B2 (https=)
EP (1) EP4114405A4 (https=)
JP (1) JP2023516648A (https=)
KR (1) KR20220148881A (https=)
CN (1) CN115515599A (https=)
AU (1) AU2021230529B2 (https=)
BR (1) BR112022017653A2 (https=)
CA (1) CA3174065A1 (https=)
IL (1) IL296093A (https=)
MX (1) MX2022010804A (https=)
WO (1) WO2021178406A1 (https=)

Families Citing this family (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CA3187268A1 (en) * 2020-06-17 2021-12-23 Amplyx Pharmaceuticals, Inc. Compounds and methods for treating fungal infections
CN116687929B (zh) * 2023-06-16 2026-04-28 山东省妇幼保健院 血根碱在制备防治临床罕见真菌相关感染性疾病药物中的应用
WO2026020112A1 (en) * 2024-07-19 2026-01-22 Sun Pharmaceutical Industries, Inc. Oral formulations of deuruxolitinib
CN119915948B (zh) * 2025-04-02 2025-07-08 天津辰欣药物研究有限公司 一种小分子真菌肌醇酰基转移酶1抑制剂原料药中致突变杂质的分析方法

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US8513287B2 (en) 2007-12-27 2013-08-20 Eisai R&D Management Co., Ltd. Heterocyclic ring and phosphonoxymethyl group substituted pyridine derivatives and antifungal agent containing same
EP2345641A1 (en) 2009-12-29 2011-07-20 Polichem S.A. New secondary 8-hydroxyquinoline-7-carboxamide derivatives
EP2636409A1 (en) * 2010-11-05 2013-09-11 Eisai R&D Management Co., Ltd. Combined pharmaceutical composition as antifungal agent
IL275121B2 (en) * 2017-12-07 2025-11-01 Amplyx Pharmaceuticals Inc Heterocycle substituted pyridine derivative antifungal agents
WO2020047510A1 (en) 2018-08-31 2020-03-05 Amplyx Pharmaceuticals, Inc. Compounds and methods for treating fungal infections
CA3187268A1 (en) 2020-06-17 2021-12-23 Amplyx Pharmaceuticals, Inc. Compounds and methods for treating fungal infections

Also Published As

Publication number Publication date
US20260102419A1 (en) 2026-04-16
CA3174065A1 (en) 2021-09-10
AU2021230529A1 (en) 2022-09-29
NZ792042A (en) 2025-09-26
JP2023516648A (ja) 2023-04-20
AU2021230529B2 (en) 2024-09-05
EP4114405A4 (en) 2024-03-13
WO2021178406A1 (en) 2021-09-10
KR20220148881A (ko) 2022-11-07
US12521406B2 (en) 2026-01-13
EP4114405A1 (en) 2023-01-11
US20230102036A1 (en) 2023-03-30
CN115515599A (zh) 2022-12-23
MX2022010804A (es) 2023-01-16
IL296093A (en) 2022-11-01

Similar Documents

Publication Publication Date Title
BR112022017653A2 (pt) Uso de compostos no tratamento de infecções fúngicas
UY38428A (es) Nuevos compuestos antihelmínticos
CO2019004137A2 (es) 1,2,4–triazolonas 2,4,5–trisustituidas
DOP2020000023A (es) Nuevos derivados de quinolina
AR112271A1 (es) Composiciones que comprenden un inhibidor de arn polimerasa y ciclodextrina para el tratamiento de infecciones virales
CO2020001242A2 (es) Dihidrooxadiazinonas
UY37952A (es) Formulaciones de un inhibidor de la quinasa trk macrocíclica
UY37201A (es) Nuevos derivados de pirazolopirimidina
CO2019011877A2 (es) Nuevos derivados de pirazol bicíclicos
UY38395A (es) Nuevos oxadiazoles
CL2022000306A1 (es) Composición fungicida
BR112022004341A2 (pt) Composições tópicas
MX380865B (es) COMPUESTOS DERIVADOS DE 1,6-DIAZABICICLO [3.2.1]OCT-3-EN-6-IL COMO INHIBIDORES DE LA ß-LACTAMASA, Y EL USO DE LOS MISMOS EN EL TRATAMIENTO DE INFECCIONES BACTERIANAS.
BRPI0516077A (pt) composições antimicrobianas compreendendo um agente natural selecionado de ácido gálico, eucalipotol, naringina, um composto de ácido jasmÈnico e qualquer combinação destes
UY39309A (es) Compuestos de isoxazolina y su uso como agentes para el control de plagas
NI202100004A (es) Compuestos de isoxazolina para controlar pl
EA202192388A1 (ru) Составы против микробиоты для чрескожного применения
BR112022014321A2 (pt) Composto antibacteriano de cefalosporina e aplicação farmacêutica do mesmo
BR112022009778A2 (pt) Álcool polivinílico ativado por carbazato (pvac) como um agente antitumoral à base de polímero
AR109409A1 (es) Compuesto de 3-piridiloxifenildihidrouracilo y su uso
MX2019002314A (es) Compuesto de 1-acetil-fenil urea, y uso del mismo.
MX391363B (es) Uso de compuesto de carbamato para prevenir, aliviar o tratar temblores o el sindrome de temblor.
MX2021004342A (es) Uso de compuesto de carbamato para prevenir, aliviar o tratar neuropatía periférica diabética o neuropatía periférica inducida por quimioterapia.
BR112022025755A2 (pt) 1,3,4-oxadiazol pirimidinas como fungicidas
BR112022024988A2 (pt) Compostos e métodos para tratamento de infecções fúngicas

Legal Events

Date Code Title Description
B25G Requested change of headquarter approved

Owner name: AMPLYX PHARMACEUTICALS, INC. (US)

B25A Requested transfer of rights approved

Owner name: BASILEA PHARMACEUTICA INTERNATIONAL AG, ALLSCHWIL (CH)